Search for dissertations about: "low molecular mass heparin"
Showing result 1 - 5 of 6 swedish dissertations containing the words low molecular mass heparin.
-
1. Unstable coronary artery disease : Studies on inflammation, infection, hemostasis, and the effects of low-molecular-mass heparin treatment
Abstract : The occurrence and prognostic importance, of inflammatory activity, signs of Chlamydia pneumoniae infection. APC resistance, hemostasis, and the effects of low-molecular-mass heparin (LMMH) was evaluated in patients with unstable coronary artery disease (UCAD). READ MORE
-
2. Role of Heparan Sulfate N-sulfation in Mouse Embryonic Development
Abstract : Heparan sulfate (HS) is a sulfated glycosaminoglycan expressed by all cells in the body. It is found at the cell surface and in the extracellular matrix where it binds a large amount of various ligands including growth factors and morphogens. READ MORE
-
3. Treatment of deep vein thrombosis and risk of recurrent venous thromboembolism
Abstract : A cute deep vein thrombosis (DVT) and pulmonary embolism (PE) are different clinical presentations of the same underlying disease, namely venous thromboembolism (VTE), which is a common and potentially fatal condition. Risk factors associated with the first and probably also subsequent events of VTE are hereditary or acquired. READ MORE
-
4. Diabetic skin microangiopathy : studies on pathogenesis and treatment
Abstract : Background: Most of late diabetic complications have their basis in a disturbed microcirculation, i.e. diabetic microangiopathy. READ MORE
-
5. Determination of the overall haemostasis potential and fibrin gel permeability : method development and application in research and in clinical materials
Abstract : We have previously developed a laboratory method that may screen the Overall Haemostasis Potential (OHP) in plasma based on spectophotometric measurement of an area under the fibrin aggregation curve in citrated plasma samples to which tiny amounts of exogenous thrombin and tissue-plasminogen activator (t-PA) are added. When the fibrin aggregation curve is created, the fibrinogen originally present in plasma is gradually converted to fibrin by the generated thrombin. READ MORE